Votre événement devrait être ici ! Pour référencer, gérer, promouvoir... Pour s'informer ou se former ... Inscriptions en ligne

Langue du site : Français - English
Réf : 26114
Evènement :20th Annual Superbugs & Superdrugs

Dates :Lundi 19 Mars 2018 - Mardi 20 Mars 2018

Lieu :Copthorne Tara Hotel
Scarsdale Place, Kensington
W8 5SY London, Royaume-Uni

Type :Conférence & Séminaire - Audience Internationale

Accréditation :--




Providing a focal point to push industry collaboration through updates on clinical advancements and investment opportunities, SMi presents the established 20th annual Superbugs & Superdrugs conference which will return to Central London on 19th and 20th March 2018.
The threat of AMR is regularly making front page news but what is the industry actually doing? Are drug manufacturers any closer to finding a solution and how is the government helping? These will be just some of the questions answered through powerful keynote addresses delivered by an expert panel of scientific leaders, drug discovery specialists and government bodies such as MHRA and DNDi.
- Richard Bax, Senior Partner, TranScrip Partners
- Lloyd Czaplewski, Dir, Chemical Biology Ventures
- Mair Powell, Senior Clinical Assessor, MHRA
- Jean-Pierre Paccaud, Dir of Business Development at GARDP, Drugs for Neglected Diseases initiative (DNDi)
- Conrad Lichtenstein, CSO, Nemesis Bioscience
- David Brown, MD & Founder, Alchemy Biomedical Consulting
- Domingo Gargallo-Viola, CSO, ABAC Therapeutics
- John George, CSO, Oppilotech
- Larry Sutton, Scientific Founder, Gladius Pharmaceuticals
- Kathy Talkington, Project Dir, Pew Charitable Trusts
- David Cook, CSO, Blueberry Therapeutics
- William Weiss, Dir of Pre-Clinical Services, UNT Health Science Center
- Cara Cassino, CMO, ContraFect
- Stephen Barat, Head of Pre-Clinical & Early Clinical Development, SCYNEXIS
- Analyze the current status of antimicrobial resistance with industry led insight into current strategies to tackle AMR 
- Hear exclusive case studies from a selection of pharmaceutical companies on clinical progress
- Learn about regulatory pathways for the registration of new antimicrobial agents 
- Evaluate the latest incentives and funding solutions to spur drug discovery 
- Explore novel alternatives to antibiotics currently in development
Early birds available online
Conference + workshop: GBP 2098
Conference: GBP 1499
Time: on Monday March 19, 2018 at 8:30 am (ends Tuesday March 20, 2018 at 5:30 pm)


Plan et itinéraire
Adresse de la conférence :
Copthorne Tara Hotel
Scarsdale Place, Kensington
W8 5SY London
Plan et itinéraire


Pour accéder aux informations vous devez être connecté. Créer un compte est facile et gratuit!

Connexion à votre compte
S'inscrire sur Doctorama


20th Annual Superbugs & Superdrugs Médecine
resistance, superbugs, superdrugs, mrsa, infectious diseases, investment, smart materials, infection
Tout public
-- -- --


Pour plus d'informations sur 20th Annual Superbugs & Superdrugs, veuillez contacter SMi Group

Pour afficher le site de l'annonceur, obtenir une lettre d'invitation, vous devez être connecté

Connexion à votre compte
S'inscrire sur Doctorama

Recommander cet évènement